6,589 results match your criteria: "Immunoglobulin G Deficiency"

Endophilin A2 Deficiency Impairs Antibody Production in Humans.

J Clin Immunol

November 2024

Department of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.

Endophilin A2, the sole endophilin A family member expressed in hematopoietic cells, regulates various aspects of membrane dynamics, including autophagy and endocytosis. Recent studies in rodents highlight the essential role of endophilin A2 in modulating immune responses. Here we report a homozygous frameshift variant in the SH3GL1 gene (NM_003025.

View Article and Find Full Text PDF
Article Synopsis
  • Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare autoimmune disorder linked to antiphospholipid syndrome, which causes severe bleeding due to low prothrombin levels, as illustrated by a case study of a 34-year-old woman with heavy menstrual bleeding and related complications.
  • The patient underwent extensive testing, revealing deficiencies in factors II and IX, leading to the initiation of immunosuppressive treatment with Rituximab and hormonal therapy with desogestrel to manage antibody levels and reduce bleeding.
  • After one year of treatment, the patient achieved complete remission, with restored levels of prothrombin and factor IX while showing reduced antibody
View Article and Find Full Text PDF

Progressive polyadenylation and m6A modification of Ighg1 mRNA maintain IgG1 antibody homeostasis in antibody-secreting cells.

Immunity

November 2024

State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Institute for Immunology, Ministry of Education Key Laboratory of Protein Sciences, Tsinghua University, Beijing, China. Electronic address:

Antigen-specific antibodies are generated by antibody-secreting cells (ASCs). How RNA post-transcriptional modification affects antibody homeostasis remains unclear. Here, we found that mRNA polyadenylations and N6-methyladenosine (m6A) modifications maintain IgG1 antibody production in ASCs.

View Article and Find Full Text PDF

Pemphigus vulgaris (PV) is an autoimmune skin disorder characterized by the loss of cell cohesion, with the histone deacetylase 1 (HDAC1) and lysine demethylase 1A (KDM1A) playing critical roles in its pathogenesis. This study aimed to elucidate the molecular mechanisms behind PV, focusing on the function of HDAC1 and KDM1A in disease onset and progression. Based on in vitro and in vivo PV models, we observed a significant increase in HDAC1 mRNA and protein levels in skin tissues of PV patients.

View Article and Find Full Text PDF

Immunoglobulins for intravenous use (IVIgs) and subcutaneous use (SCIgs) can prevent recurrent and severe infections in patients with secondary antibody deficiencies that are frequently linked to haematological/oncological malignancies as well as other clinical conditions and their respective treatments. Even so, as IVIgs and SCIgs are costly and their supply is limited, their clinical use must be optimised. The aim of this position paper is to provide structured practical guidance on the optimal use of IVIgs and SCIgs in secondary antibody deficiencies, particularly in haematological and oncological practice.

View Article and Find Full Text PDF

Rationale: Serum Immunoglobulin G (IgG) deficiency is associated with morbidity in chronic obstructive pulmonary disease (COPD) but it is unclear whether concentrations in the lower end of the normal range still confer risk.

Objectives: To determine if levels above traditional cutoffs for serum IgG deficiency are associated with exacerbations among current and former smokers with or at risk for COPD.

Measurements And Main Results: Former and current smokers in SPIROMICS (n=1,497) were studied, n=1,026 with and n=471 at risk for COPD.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers measured the prevalence of IgG anti-IgA in PID patients compared to healthy controls and found a low percentage of PID patients with these antibodies and hypersensitivity.
  • * The study suggests that complement activation might be a more significant factor in hypersensitivity reactions to immunoglobulin preparations, rather than just the presence of IgG anti-IgA.
View Article and Find Full Text PDF

Low incidence of primary immunodeficiency-associated cancers in children at a tertiary care pediatric hospital in Pakistan: a blessing in disguise or wet behind the ears?

Ecancermedicalscience

July 2024

Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, University of Child Health Sciences, The Children's Hospital, Lahore 54600, Pakistan.

Article Synopsis
  • There is limited data on cancers associated with primary immunodeficiencies (PIDs) in children in low-middle-income countries, so this study examined their incidence and outcomes in Pakistan.
  • Out of 5,748 children with cancers, only eight had PID-associated malignancies, resulting in an incidence rate of 1.4 per 1,000, with a median diagnosis age of 6.5 years and a 7:1 male-to-female ratio.
  • The prognosis for these patients was poor, with a median survival of only 3.5 months, primarily due to infection-related deaths; the study suggests improved awareness and screening for PIDs might enhance treatment outcomes.
View Article and Find Full Text PDF

Sensory neurons sense pathogenic infiltration to drive innate immune responses, but their role in humoral immunity is unclear. Here, using mouse models of Streptococcus pneumoniae infection and Alternaria alternata asthma, we show that sensory neurons are required for B cell recruitment and antibody production. In response to S.

View Article and Find Full Text PDF
Article Synopsis
  • Primary atopic disorders (PAD) are rare genetic conditions caused by specific gene variants that affect skin and immune function, making diagnosis challenging among common allergic disease cases.
  • Identifying PAD requires recognizing clinical red flags like family history and unusual infections, as conventional lab tests are inadequate for definitive diagnosis.
  • Whole-genome sequencing (WGS) enhances diagnostic efficiency and accuracy, but requires careful interpretation and collaboration among specialists to effectively manage PAD cases.
View Article and Find Full Text PDF
Article Synopsis
  • MGUS-associated angioedema due to acquired C1 inhibitor deficiency (AAE-C1-INH) hasn't been specifically characterized before, prompting this study to explore its biological and clinical features over 30 years in France.
  • In a study of 41 patients, most had anti-C1INH antibodies, and treatments included acute management and long-term prophylaxis, with a significant number developing malignant blood disorders like lymphoma or myeloma.
  • The study found a link between the remission of angioedema and the underlying hematological malignancy, emphasizing the need for regular hematological evaluations in patients with MGUS-AE-C1-INH.
View Article and Find Full Text PDF

Antibodies provide an essential layer of protection from infection and reinfection with microbial pathogens. An impaired ability to produce antibodies results in immunodeficiency and necessitates the constant substitution with pooled serum antibodies from healthy donors. Among the five antibody isotypes in humans and mice, immunoglobulin G (IgG) antibodies are the most potent anti-microbial antibody isotype due to their long half-life, their ability to penetrate almost all tissues and due to their ability to trigger a wide variety of effector functions.

View Article and Find Full Text PDF

COL6A6 Peptide Vaccine Alleviates Atherosclerosis through Inducing Immune Response and Regulating Lipid Metabolism in Mice.

Cells

September 2024

Department of Pathophysiology, Key Lab for Shock and Microcirculation Research of Guangdong, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.

Article Synopsis
  • Atherosclerosis is a disease that affects blood vessels and is caused by fat imbalances and inflammation, and there aren't many ways to prevent or treat it right now.
  • Scientists created a vaccine called Pep_A6, which they tested on mice to see if it could help against this disease.
  • The results showed that the vaccine helped reduce harmful plaque in the blood vessels, changed the immune system in a good way, and improved fat levels in the body, suggesting it could be a new way to prevent atherosclerosis.
View Article and Find Full Text PDF

Threonine Phosphorylation and the Yin and Yang of STAT1: Phosphorylation-Dependent Spectrum of STAT1 Functionality in Inflammatory Contexts.

Cells

September 2024

Laboratory of Immune Regulation, Immunology Frontier Research Center, The World Premier International Research Center Initiative (WPI), Osaka University, Osaka 565-0871, Japan.

Threonine phosphorylation promotes inflammatory functions of STAT1 while restricting its interferon (IFN) signaling in innate immune responses. However, it remains unclear whether the restriction of STAT1-mediated IFN signaling conferred by threonine phosphorylation is a ubiquitous mechanism or one that is context-dependent. To address this, we utilized pristane-induced lupus, a prototype IFN-driven systemic autoimmune disease model characterized by the production of high-titer autoantibodies against nucleic acid-associated antigens.

View Article and Find Full Text PDF

Visualizing Immune Checkpoint Inhibitors Derived Inflammation in Atherosclerosis.

Circ Res

October 2024

Mallinckrodt Institute of Radiology (L.L., L.D., H.L., D.S., A.L., D.L., X.Z., G.S.H., Y.L.), Washington University, St. Louis, MO.

Background: Immune checkpoint inhibitor (ICI) usage has resulted in immune-related adverse events in patients with cancer, such as accelerated atherosclerosis. Of immune cells involved in atherosclerosis, the role of CCR2+ (CC motif chemokine receptor 2-positive) proinflammatory macrophages is well documented. However, there is no noninvasive approach to determine the changes of these cells in vivo following ICI treatment and explore the underlying mechanisms of immune-related adverse events.

View Article and Find Full Text PDF

Immunoglobulin therapies for primary immunodeficiency diseases (part 2): considerations for dosing strategies.

Immunotherapy

October 2024

Clinical Pharmacology & Early Clinical Development, Takeda Development Center Americas, Inc., Cambridge, MA 02142, USA.

Article Synopsis
  • - Immunoglobulin G (IgG) dosing for primary immunodeficiency diseases (PIDs) is personalized, taking into account individual patient experiences, clinical status, and physician input.
  • - Regular monitoring of serum IgG levels is crucial for both diagnosing PIDs and adjusting IgG treatment plans, and this process should not be done alone but as part of a broader care strategy.
  • - The review explores current and future IgG dosing strategies, considering distinct patient groups, such as those new to immunoglobulin therapy and those transitioning between intravenous (IVIG) and subcutaneous (SCIG) administration.
View Article and Find Full Text PDF

Immunoglobulin therapies for primary immunodeficiency diseases (part 1): understanding the pharmacokinetics.

Immunotherapy

October 2024

Clinical Pharmacology & Early Clinical Development, Takeda Development Center Americas, Inc., Cambridge, MA 02142, USA.

Article Synopsis
  • * There are significant gaps in knowledge regarding how IgGs work and are processed in the body, influenced by various patient-specific factors that require personalized treatment approaches.
  • * A literature review was conducted to explore IgG PK, the mechanisms behind their metabolism, considerations for different patient groups, and to identify knowledge gaps and future research directions to enhance understanding of IgG treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Infantile-onset Pompe disease (IOPD) is a serious condition caused by a deficiency in the enzyme acid alpha-glucosidase, leading to severe heart and muscle problems that can be fatal within the first 2 years without treatment.
  • Enzyme replacement therapy (ERT) with alglucosidase-alfa is crucial for treatment, but its success can be affected by factors like the patient's immune response and CRIM status.
  • A case study of CRIM-negative twins treated with high-dose ERT and immune tolerance induction showed significant improvements in cardiac function and biomarkers, highlighting the importance of early intervention in managing IOPD.
View Article and Find Full Text PDF
Article Synopsis
  • PI3K is involved in immune function, and defects in the PI3K/AKT/mTOR pathway lead to issues like recurrent infections, autoimmunity, and abnormal immune cell proliferation.
  • The study analyzed 12 patients with different PIK3 variants, revealing a long diagnostic delay and common symptoms such as respiratory infections and autoimmune issues in those with activated PI3K delta syndrome (APDS).
  • Molecular genetic analysis is essential for accurate diagnosis of these immune defects, as laboratory findings can help distinguish between APDS and other conditions related to immune dysregulation.
View Article and Find Full Text PDF
Article Synopsis
  • * Diagnosis typically occurs after age 2, as children have limited polysaccharide responsiveness that matures over time; there’s still uncertainty over specific testing thresholds for nonresponse.
  • * Management includes monitoring and potential treatments like prophylactic antibiotics and immunoglobulin replacement, with a better chance of resolution in children compared to older patients.
View Article and Find Full Text PDF
Article Synopsis
  • Immunoglobulin G (IgG) subclass deficiencies and isolated deficiencies in IgA, IgM, and IgE have been documented, showing varying prevalence and symptoms ranging from asymptomatic to recurrent infections that don't respond to antibiotics.
  • These deficiencies are often linked with other health issues like atopic disorders and autoimmune diseases, particularly in patients lacking allergies or with certain immunodeficiency types.
  • Treatment options vary and may include antibiotics for infections, prophylactic measures for some patients, and immunoglobulin replacement for those who have frequent, severe infections.
View Article and Find Full Text PDF

Autoantibodies to ADAMTS13 in human immunodeficiency virus-associated thrombotic thrombocytopenic purpura.

Vox Sang

December 2024

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Background And Objectives: Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal thrombotic microangiopathic disorder that can result from human immunodeficiency virus (HIV) infection. The pathogenesis involves a deficiency of the von Willebrand factor (vWF) cleaving protease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin motifs member 13) and the presence of anti-ADAMTS13 autoantibodies. However, there is insufficient information regarding the epitope specificity and reactivity of these autoantibodies.

View Article and Find Full Text PDF

Introduction/aims: Hypogammaglobulinemia is a common yet under-recognized feature of myotonic dystrophy type 1 (DM1). The aims of our study were to determine the frequency of immunoglobulin G (IgG) deficiency in our cohort, to examine the association between immunoglobulin levels and cytosine-thymine-guanine (CTG) repeat length in the DMPK gene, and to assess whether IgG levels are associated with an increased risk of infection in DM1 patients.

Methods: We conducted a single-center, retrospective cross-sectional study of 65 adult patients with DM1 who presented to the Neuromuscular Clinic at Concord Repatriation General Hospital, Sydney, Australia, between January 2002 and January 2022.

View Article and Find Full Text PDF
Article Synopsis
  • * The study analyzed data from a large US database, revealing that 70.1% of patients with CLL/SLL and SID experienced infections versus 30.4% of those without SID, and those with SID had a shorter overall survival (12.3 vs. 16.9 months).
  • * IgRT-treated patients with CLL/SLL and SID experienced even greater infection-related burdens and healthcare resource utilization, indicating a pressing need for more research on effective treatment
View Article and Find Full Text PDF
Article Synopsis
  • Lautropia mirabilis is a Gram-negative bacterium associated with respiratory infections in patients with weakened immune systems, such as those with HIV or cystic fibrosis; however, its pathogenicity is not well understood due to limited cases.
  • A 39-year-old female with common variable immunodeficiency (CVID) experienced sepsis caused by L. mirabilis, which was identified through blood cultures and effectively treated with meropenem.
  • Whole genome sequencing of L. mirabilis showed genes that aid in invading host cells and surviving inside them, underscoring the need to recognize its potential danger beyond respiratory infections in immunocompromised individuals.
View Article and Find Full Text PDF